Mortality after hematopoietic stem cell transplantation for severe mucopolysaccharidosis type I: the 30-year University of Minnesota experience

Journal of Inherited Metabolic Disease

Volumn 40, Issue 2, 2017, Pages 271-280

  Rodgers, Nathan J ^a   Kaizer, Alexander M ^b   Miller, Weston P ^c   Rudser, Kyle D ^b   Orchard, Paul J ^c   Braunlin, Elizabeth A ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ADULT RESPIRATORY DISTRESS SYNDROME; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BACTERIAL INFECTION; CARDIOMYOPATHY; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEART ARREST; HUMAN; HURLER SYNDROME; INCIDENCE; INFANT; LONG TERM SURVIVAL; LUNG FIBROSIS; LUNG HEMORRHAGE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MINNESOTA; MORTALITY; MYCOSIS; OVERALL SURVIVAL; PRESCHOOL CHILD; RESPIRATORY TRACT DISEASE; RETROSPECTIVE STUDY; SEX DIFFERENCE; VIRUS INFECTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; PROCEDURES;

CHILD, PRESCHOOL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; MALE; MINNESOTA; MUCOPOLYSACCHARIDOSIS I; RETROSPECTIVE STUDIES;

EID: 85008240123     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-016-0006-2     Document Type: Article

References (28)

1. Aldenhoven M, Wynn RF, Orchard PJ, O’Meara A, Veys P, Fischer A, Valayannopoulos V et al (2015) Long-term outcome of Hurler syndrome patients after hematopoietic cell transplantation: an international multicenter study. Blood 125(13):2164–2172
2. Ansari M, Theoret Y, Rezgui MA, Peters C, Mezziani S, Desjean C, Vachon MF et al (2014) Association between busulfan exposure and outcome in children receiving intravenous busulfan before hematopoietic stem cell transplantation. Ther Drug Monit 36(1):93–99
3. Arias E (2002) United States Life Tables, 2000. Ntnl Vital Stat Rep, Centers Dis Control 51:1–39
4. Boelens JJ, Wynn RF, O’Meara A, Veys P, Bertrand Y, Souillet G, Wraith JE et al (2007) Outcomes of hematopoietic stem cell transplantation for Hurler’s syndrome in Europe: a risk factor analysis for graft failure. Bone Marrow Transplant 40(3):225–233
5. Boelens JJ, Rocha V, Aldenhoven M, Wynn R, O’Meara A, Michel G, Ionescu I et al (2009) Risk factor analysis of outcomes after unrelated cord blood transplantation in patients with Hurler syndrome. Biol Blood Marrow Transplant 15(5):618–625
6. Boelens JJ, Aldenhoven M, Purtill D, Ruggeri A, Defor T, Wynn R, Wraith E et al (2013) Outcomes of transplantation using various hematopoietic cell sources in children with Hurler syndrome after myeloablative conditioning. Blood 121(19):3981–3987
7. Centers for Disease Control (1984) Life Tables. Vital Statistics of the United States, 1980
8. Centers for Disease Control (1994) Life Tables. Vital Statistics of the United States, 1990
9. Coletti HY, Aldenhoven M, Yelin K, Poe MD, Kurtzberg J, Escolar ML (2015) Long-term functional outcomes of children with Hurler syndrome treated with unrelated umbilical cord blood transplantation. JIMD Rep 20:77–86
10. Cox-Brinkman J, Boelens JJ, Wraith JE, O’Meara A, Veys P, Wijburg FA, Wulffraat N et al (2006) Haematopoietic cell transplantation (HCT) in combination with enzyme replacement therapy (ERT) in patients with Hurler syndrome. Bone Marrow Transplant 38(1):17–21
11. Ghosh A, Miller W, Orchard PJ, Jones SA, Mercer J, Church HJ, Tylee K et al (2016) Enzyme replacement therapy prior to haematopoietic stem cell transplantation in Mucopolysaccharidosis Type I: 10 year combined experience of 2 centres. Mol Genet Metab 117(3):373–377
12. Guffon N, Souillet G, Maire I, Straczek J, Guibaud P (1998) Follow-up of nine patients with Hurler syndrome after bone marrow transplantation. J Pediatr 133(1):119–125
13. Hamidieh AA, Alimoghaddam K, Jahani M, Bahar B, Mousavi SA, Iravani M, Behfar M et al (2013) Non-TBI hematopoietic stem cell transplantation in pediatric AML patients: a single-center experience. J Pediatr Hematol Oncol 35(6):e239–e245
14. Hobbs JR, Hugh-Jones K, Barrett AJ, Byrom N, Chambers D, Henry K, James DC et al (1981) Reversal of clinical features of Hurler’s disease and biochemical improvement after treatment by bone-marrow transplantation. Lancet 2(8249):709–712
15. Krivit W, Sung JH, Shapiro EG, Lockman LA (1995) Microglia: the effector cell for reconstitution of the central nervous system following bone marrow transplantation for lysosomal and peroxisomal storage diseases. Cell Transplant 4(4):385–392
16. Krovetz LJ, Lorincz AE, Schiebler GL (1965) Cardiovascular Manifestations of the Hurler Syndrome: Hemodynamic and Angiocardiographic Observations in 15 Patients. Circulation 31:132–141
17. Mitchell R, Nivison-Smith I, Anazodo A, Tiedemann K, Shaw PJ, Teague L, Fraser CJ et al (2013) Outcomes of haematopoietic stem cell transplantation for inherited metabolic disorders: a report from the Australian and New Zealand Children’s Haematology Oncology Group and the Australasian Bone Marrow Transplant Recipient Registry. Pediatr Transplant 17(6):582–588
18. Moore D, Connock MJ, Wraith E, Lavery C (2008) The prevalence of and survival in Mucopolysaccharidosis I: Hurler, Hurler-Scheie and Scheie syndromes in the UK. Orphanet J Rare Dis 3:24
19. Neufeld EF, Muenzer J (2001) The Mucopolysaccharidoses. The Metabolic & Molecular Bases of Inherited Disease. C. R. Scriver, A. L. Beaudet, W. S. Sly and D. Valle. New York, McGraw-Hill. III: 3421-3482.
20. Orchard PJ, Milla C, Braunlin E, DeFor T, Bjoraker K, Blazar BR, Peters C et al (2010) Pre-transplant risk factors affecting outcome in Hurler syndrome. Bone Marrow Transplant 45(7):1239–1246
21. Peters C, Balthazor M, Shapiro EG, King RJ, Kollman C, Hegland JD, Henslee-Downey J et al (1996) Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome. Blood 87(11):4894–4902
22. Peters C, Shapiro EG, Anderson J, Henslee-Downey PJ, Klemperer MR, Cowan MJ, Saunders EF et al (1998) Hurler syndrome: II. Outcome of HLA-genotypically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children. Storage Dis Collab Study Group Blood 91(7):2601–2608
23. R-Core Team (2016) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria
24. Souillet G, Guffon N, Maire I, Pujol M, Taylor P, Sevin F, Bleyzac N et al (2003) Outcome of 27 patients with Hurler’s syndrome transplanted from either related or unrelated haematopoietic stem cell sources. Bone Marrow Transplant 31(12):1105–1117
25. Spellman S, Setterholm M, Maiers M, Noreen H, Oudshoorn M, Fernandez-Vina M, Petersdorf E et al (2008) Advances in the selection of HLA-compatible donors: refinements in HLA typing and matching over the first 20 years of the National Marrow Donor Program Registry. Biol Blood Marrow Transplant 14(9 Suppl):37–44
26. Staba SL, Escolar ML, Poe M, Kim Y, Martin PL, Szabolcs P, Allison-Thacker J et al (2004) Cord-blood transplants from unrelated donors in patients with Hurler’s syndrome. N Engl J Med 350(19):1960–1969
27. Tolar J, Orchard PJ (2008) Alpha-L-iduronidase therapy for mucopolysaccharidosis type I. Biologics 2(4):743–751
28. Vellodi A, Young EP, Cooper A, Wraith JE, Winchester B, Meaney C, Ramaswami U et al (1997) Bone marrow transplantation for mucopolysaccharidosis type I: experience of two British centres. Arch Dis Child 76(2):92–99